Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
about
The rationale for platelet transfusion during cardiopulmonary bypass: an observational study.Clinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor-recipient continuumThe impact of peri-operative blood transfusions on post-pancreatectomy short-term outcomes: an analysis from the American College of Surgeons National Surgical Quality Improvement Program.Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination.Transfusion and risk of infection in Canada: Update 2012.Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors.The impact of blood transfusion on perioperative outcomes following gastric cancer resection: an analysis of the American College of Surgeons National Surgical Quality Improvement Program databaseQuality Assessment of Established and Emerging Blood Components for Transfusion.Effect of blood donor characteristics on transfusion outcomes: a protocol for systematic review and meta-analysis.Estimating the prevalence of multiple diseases from two-stage hierarchical pooling.The proportion and trend of human immunodeficiency virus infections associated with men who have sex with men from Chinese voluntary blood donors: a systematic review and meta-analysis.Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study.A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors.A decision model and cost analysis of intra-operative cell salvage during hepatic resectionResidual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.Impact of a 5-year deferral from blood donation for men who have sex with men.Estimating the residual risk for HIV, HCV and HBV in different types of platelet concentrates in Germany.Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.Donor criteria for men who have sex with men: a Canadian perspective.A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening.The current incidence, prevalence, and residual risk of hepatitis B viral infections among voluntary blood donors in China.Understanding Perioperative Transfusion Practices in Gastrointestinal Surgery-a Practice Survey of General Surgeons.The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.The impact of perioperative blood transfusions on short-term outcomes following hepatectomy.Hepatitis C surveillance in Canada.Les transfusions et le risque d’infection au Canada : mise à jour pour 2012.Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey
P2860
Q33405467-308F1ADA-7CE7-4816-AE66-2B54AC7CB288Q35008190-627941FE-9635-411C-BB31-1A2A433C5362Q36160746-0130CEEE-80C6-4AF8-90FC-02CC8E3FF888Q36408117-A57C5D23-AE34-4278-BB70-879DDBEBFB6BQ36547648-AB9512DE-4EA0-4F90-95FB-EDAC42BA40DCQ36652701-713691C8-0C91-42F4-944F-52E797BA4DA8Q37297382-77EECCFE-3C62-41AC-B00D-E854AD5DEDD9Q37539104-CBF071EF-8572-400D-95B5-1BFD98BDAECEQ37720799-DB9D7E9D-5BF8-428E-90E2-DEED41742EEEQ37836714-F6A0B37D-D56F-49F9-85F4-865FA1FCAD08Q38261600-17599CE8-3386-4C12-9382-28C2F892C913Q39064863-6F810FB8-25B0-4921-B7BC-0F8997888797Q39137413-81DD892F-9DF5-41A4-A6BF-9C0ABA4EA091Q39786970-9EF22FF6-421E-4B45-BC6C-FAADCC52AFA4Q40169707-73DC2AEC-4D4D-411F-A366-4AA0A50ACC32Q40850337-26E48E29-EA96-468E-BCF5-3286CE1B9FC5Q41692988-2D6DCAF6-5968-4D64-8FD1-7E5E43643C24Q42158238-B23B6DB6-FE41-47CF-B9FB-AA5AE834D4F7Q42205133-0AB44B97-10C5-4EB9-ABD0-CACBB069BBE0Q42257442-B4EC948B-B327-468B-917D-32970E00B3FEQ47134046-76CBBDB9-FFD1-4AA6-AF7F-F3B5856A2D57Q47447566-769A2C97-4CCE-4E3D-8E74-2BEB1E1F9BACQ50450374-22D60D5B-5DA1-40D5-9139-2B2EB8F60243Q52726979-AC594FAD-EA72-42B3-9A24-6BB69FF55C23Q54943389-5BDCA39B-CB52-44E9-B593-13A2447F52DFQ55077149-E8D290D8-015B-48D1-8A90-526FCCA9B06DQ58776091-10D6C0B4-7420-4251-9756-1557AB5E5AED
P2860
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
@en
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
@nl
type
label
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
@en
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
@nl
prefLabel
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
@en
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
@nl
P2093
P2860
P1433
P1476
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
@en
P2093
P2860
P356
10.1111/J.1423-0410.2012.01584.X
P577
2012-01-31T00:00:00Z